These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38814188)

  • 1. Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
    Tandon R; Agakishiev D; Freese RL; Thompson J; Nijjar PS
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230402. PubMed ID: 38814188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmic effects of ivabradine in patients with coronary artery disease.
    Murat SN; Orcan S; Akdemir R; Dogan M; Kara E; Balci M
    Clin Invest Med; 2009 Oct; 32(5):E322-6. PubMed ID: 19796572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ivabradine on structural and functional changes of myocardium and NT-proBNP levels in patients with stable coronary heart disease after coronary stenting.
    Kupnovytska IH; Romanyshyn NM; Fitkovska IP; Gubina NV; Krasnopolsky SZ; Klymenko VI; Kalugina SM
    Wiad Lek; 2024; 77(4):800-810. PubMed ID: 38865640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ivabradine for control of heart rate during coronary CT angiography: A randomized, double-blind, placebo-controlled trial.
    Cademartiri F; Garot J; Tendera M; Zamorano JL
    J Cardiovasc Comput Tomogr; 2015; 9(4):286-94. PubMed ID: 26088378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart-Rate Reduction With Adjusted-Dose Ivabradine in Patients Undergoing Coronary Computed Tomographic Angiography: A Randomized Trial.
    Kacijan B; Novak Z; Jug B; Dolenc Novak M; Vrtovec M; Gužič Salobir B
    J Comput Assist Tomogr; 2017; 41(3):360-363. PubMed ID: 27861199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.
    Porres-Aguilar M; Muñoz OC; Abbas A
    Curr Cardiol Rep; 2016 Feb; 18(2):13. PubMed ID: 26768739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
    Deedwania P
    Drugs; 2013 Sep; 73(14):1569-86. PubMed ID: 24065301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of point-of-care oral ivabradine for cardiac computed tomography.
    Guler EC; Yam Y; Jia K; El Mais H; Hossain A; Chow BJW; Small GR
    J Cardiovasc Comput Tomogr; 2021; 15(3):226-231. PubMed ID: 33039320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different strategies of ivabradine premedication for heart rate reduction before coronary computed tomography angiography.
    Celik O; Atasoy MM; Erturk M; Yalcin AA; Aksu HU; Diker M; Akturk FI; Erkanli K; Atasoy I; Kiris A
    J Cardiovasc Comput Tomogr; 2014; 8(1):77-82. PubMed ID: 24582046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease.
    Hohneck AL; Fries P; Ströder J; Schneider G; Wagenpfeil S; Schirmer SH; Böhm M; Laufs U; Custodis F
    J Hypertens; 2019 May; 37(5):1023-1031. PubMed ID: 30672832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy.
    Lupi A; Rognoni A; Cavallino C; Secco GG; Rosso R; Bongo AS
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):4-9. PubMed ID: 25544120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
    Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
    Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
    Gloekler S; Traupe T; Stoller M; Schild D; Steck H; Khattab A; Vogel R; Seiler C
    Heart; 2014 Jan; 100(2):160-6. PubMed ID: 24186565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography.
    Pichler P; Pichler-Cetin E; Vertesich M; Mendel H; Sochor H; Dock W; Syeda B
    Am J Cardiol; 2012 Jan; 109(2):169-73. PubMed ID: 22011557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen.
    Guaricci AI; Maffei E; Brunetti ND; Montrone D; Di Biase L; Tedeschi C; Gentile G; Macarini L; Midiri M; Cademartiri F; Di Biase M
    Int J Cardiol; 2013 Sep; 168(1):362-8. PubMed ID: 23063141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography.
    Adile KK; Kapoor A; Jain SK; Gupta A; Kumar S; Tewari S; Garg N; Goel PK
    Br J Radiol; 2012 Aug; 85(1016):e424-8. PubMed ID: 22815422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Ivabradine versus β-Blockers for Heart Rate Reduction during Computed Tomography Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Qiu S; Shi S; Ping H; Zhou S; Wang H; Yang B
    Cardiology; 2016; 135(3):133-140. PubMed ID: 27328446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting.
    Muster V; Wallner M; Schmidt A; Kapl M; von Lewinski F; Rainer P; Reittner P; Tillich M; Brader P; Szolar DH; von Lewinski D
    J Int Med Res; 2018 Jun; 46(6):2249-2257. PubMed ID: 29614895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.